<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.2" -->
<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/">
<channel>
	<title>Comments on: Will Technological Improvements Eliminate Reliance on Heart Transplantation?</title>
	<link>http://www.reportbuyer.com/blog/will-technological-improvements-eliminate-reliance-on-heart-transplantation/</link>
	<description>Sharing intelligence</description>
	<pubDate>Thu, 21 Aug 2008 23:01:00 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.2</generator>

	<item>
		<title>By: Joann</title>
		<link>http://www.reportbuyer.com/blog/will-technological-improvements-eliminate-reliance-on-heart-transplantation/#comment-114171</link>
		<author>Joann</author>
		<pubDate>Fri, 11 Jul 2008 07:16:35 +0000</pubDate>
		<guid>http://www.reportbuyer.com/blog/will-technological-improvements-eliminate-reliance-on-heart-transplantation/#comment-114171</guid>
		<description>The pharmacological strategies are improving the survival rates of acute and early-stage heart failure patients, ironically providing a growing body of patients with progression of the disease to heart failure. With no new drug therapies addressing advanced heart failure and existing pharmacological strategies failing to compensate for a weakening heart, alternative solutions have to be found. In view of long waiting lists for heart transplantation and the growing lack of donor hearts, significant numbers of patients die while waiting for a heart transplant. But cardiac resynchronization therapy, mechanical circulatory support devices and other alternative technologies have demonstrated promising results, and the continuing rapid technological developments in this area suggest we may only be a decade away from eliminating the reliance on heart transplantation,</description>
		<content:encoded><![CDATA[<p>The pharmacological strategies are improving the survival rates of acute and early-stage heart failure patients, ironically providing a growing body of patients with progression of the disease to heart failure. With no new drug therapies addressing advanced heart failure and existing pharmacological strategies failing to compensate for a weakening heart, alternative solutions have to be found. In view of long waiting lists for heart transplantation and the growing lack of donor hearts, significant numbers of patients die while waiting for a heart transplant. But cardiac resynchronization therapy, mechanical circulatory support devices and other alternative technologies have demonstrated promising results, and the continuing rapid technological developments in this area suggest we may only be a decade away from eliminating the reliance on heart transplantation,</p>
]]></content:encoded>
	</item>
</channel>
</rss>
